article Open AccessTop 1% cited
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
Molecular Pharmacology · 1993 · Vol. 43(3) · pp. 320–327
Frederick J. Monsma✉(National Institutes of Health)Yong Shen(National Institutes of Health)Raymond P. Ward(National Institute of Neurological Disorders and Stroke)Mark W. Hamblin(University of Washington)David R. Sibley(National Institute of Neurological Disorders and Stroke)
Neurotransmitter Receptor Influence on BehaviorSerotoninReceptor5-HT receptorTricyclicBiologyBiochemistryMolecular biologyChemistryPharmacology
MeSH terms
Amino Acid SequenceAnimalsBase SequenceBinding, CompetitiveBrain ChemistryCell LineCloning, MolecularDNALysergic Acid DiethylamideMolecular Sequence DataPsychotropic DrugsReceptors, SerotoninRNASerotoninSerotonin Antagonists
Citations
598
FWCI
9.90
field-weighted impact
References
0
Percentile
99%
vs. same field & year
Citations per year
Cited by
Molecular biology of 5-HT receptors
Neuropharmacology · 1994 · 679 citations
A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635
European Journal of Pharmacology · 1995 · 609 citations
A review of central 5-HT receptors and their function
Neuropharmacology · 1999 · 3,157 citations
Inflammation and Alzheimer's disease
Neurobiology of Aging · 2000 · 4,492 citations
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Neuropsychopharmacology · 2003 · 967 citations
SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist
Neuropharmacology · 1997 · 523 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
